Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-Center, Randomized Evaluation of an IMPRA/Bard ePTFE Encapsulated Carbon Lined Nitinol Endoluminal Device for AV Access Graft Stenoses

NCT00678249 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.

NCT NCT00678249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00678249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-Center, Randomized Evaluation of an IMPRA/Bard ePTFE Encapsulated Carbon Lined Nitinol Endoluminal Device for AV Access Graft Stenoses
Lead sponsor
C. R. Bard
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2001
Completion date
June 30, 2004
Enrollment
227 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stenoses